Lancets Market Size, Share & Trends Analysis Report By Type (Safety Lancets, Standard Lancets, Specialty Lancets), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Lancets Market Size, Share & Trends Analysis Report By Type (Safety Lancets, Standard Lancets, Specialty Lancets), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030


Terminal Sterilization Services Market Growth & Trends

The global terminal sterilization services market size is expected to reach USD 24.39 billion by 2030, registering a CAGR of 11.08% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing the number of hospital-acquired infections globally is likely to stimulate the market demand. For instance, as per the Patient Care Link Organization, in the U.S. alone, the CDC has estimated that hospital-acquired infections account for 1.7 million infections & 99,000 HAIs-associated deaths. Terminal sterilization services help in sterilizing instruments used during surgical cases. Thus, with the increase in number of HAIs, hospitals are expected to use terminal sterilizers, thereby, impelling the market during the forecast period.

In addition, the increase in surgical procedures is expected to increase the demand for terminal sterilization services during the forecast period. For instance, as per Jama Network, there were an estimated number of 13,108,567 surgical procedures identified in 2019 in the U.S. Similarly, according to the Australian Institute of Health & Welfare, 754,600 patients were admitted for surgery in the public hospitals. Moreover, as per a similar source, the gastrointestinal endoscopy had the largest growth of 107% in 2018. Endoscope needs to be sterilized after their use, and are sterilized by moist heating. Thus, with the increase in number of endoscopic procedures, the market is expected to impel during the forecast period.

Furthermore, with a decline in population suffering from COVID-19, the earlier postponed elective surgeries are expected to be scheduled in near future, as a result, the risk of HAIs and other infections in anticipated to increase. Additionally, many companies were involved in various strategies such as merger & acquisition, product development, & geographic expansion. For instance, in September 2021, Nelson Labs & Sterigenics Germany GmbH announced opening a laboratory and expanding its sterilization facilities in Wiesbaden, Germany. This was expected to help the company capitalize on the growing demand for sterilization facilities. Thus, due to the aforementioned factors, the terminal sterilization services market is anticipated to grow significantly during the post-COVID period.

Terminal Sterilization Services Market Report Highlights
  • The ethylene oxide segment dominated the market with the largest revenue share of 40.99% in 2024. This growth can be attributed to its effectiveness in sterilizing a wide range of heat-sensitive medical devices.
  • The hospitals & clinics segment dominated the market in 2024 and is expected to witness the fastest growth over the forecast period. The increasing burden of HAIs is primarily boosting the demand for sterilization in hospitals and other healthcare settings.
  • The North America terminal sterilization services market held the largest revenue share of 35.43% in 2024.
  • The Asia Pacific terminal sterilization services market is set for significant growth, driven by several key factors such as the presence of numerous local players in countries such as China and Japan, as these companies introduce innovative products tailored to regional needs, increasing competition and accessibility.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Lancets Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Lancets Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Safety Lancets
4.4.1. Safety lancets market, 2018 - 2030 (USD Million)
4.5. Standard Lancets Devices
4.5.1. Standard lancets devices market, 2018 - 2030 (USD Million)
Chapter 5. Lancets Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis by Application, 2018 to 2030 (USD Million)
5.4. Blood Glucose Testing
5.4.1. Blood glucose testing market, 2018 - 2030 (USD Million)
5.5. Hemoglobin Testing
5.5.1. Hemoglobin testing market, 2018 - 2030 (USD Million)
5.6. Cholesterol Testing
5.6.1. Cholesterol testing market, 2018 - 2030 (USD Million)
5.7. Coagulation Testing
5.7.1. Coagulation testing market, 2018 - 2030 (USD Million)
5.8. Infectious Disease Testing
5.8.1. Infectious disease testing market, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others market, 2018 - 2030 (USD Million)
Chapter 6. Lancets Market: End Use Business Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals & Clinics
6.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
6.5. Homecare Settings
6.5.1. Homecare Settings market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others market, 2018 - 2030 (USD Million)
Chapter 7. Lancets Market: Regional Estimates & Trend Analysis by Type, Application, and End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. UK lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. Germany lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. Australia lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. South Korea lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE lancets market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait lancets market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. BD
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. Roche Diagnostics
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Medline Industries, LP.
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. EQT AB
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. MTD Medical Technology and Devices
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. B. Braun SE
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Terumo Medical Corporation
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Owen Mumford
8.5.8.1. .Overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Arkray
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. AgaMatrix
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Nipro Europe Group Companies
8.5.11.1. Overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings